SA

Spectral AI, Inc.

MDAI·NASDAQ

$2.01

+0.75%
HealthcareMedical - Devices

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

At a Glance

Live Snapshot
Market Cap$63.97M
EPS-0.2900
P/E Ratio-6.93
Earnings Date08/11/2026

mdai

Other Current Liabilities

Last Annual Value

13.87M

3-Year CAGR

376%

5-Year CAGR

168%

10-Year CAGR

64%

SA

Spectral AI, Inc. Competitors Analysis of Other Current Liabilities

MDAI · NASDAQ
CompanyOther Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
13.87M
96.9%64.8%N/A 
161.05K
-33.8%N/AN/A
12.13M
64.5%62.2%N/A
275.00K
-20.0%-11.6%21.1%
1.82M
-20.7%-11.7%N/A
5.66M
34.2%-25.1%-13.4%
2.26M
17.8%468.9%N/A
14.56M
22.7%25.2%N/A
3.78M
112.1%N/A3.0%
66.08M
53.8%26.5%23.1%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
15.67M
41.6%37.8%N/A
SA

Spectral AI, Inc. Fair Value Envelope

MDAI · NASDAQ

Our analysis suggests that MDAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.01, this represents a potential HIDDEN relative to our calculated worth for Spectral AI, Inc..

Intrinsic Value
Current Price: $2.01